Globus Medical
$ 77.95
-0.38%
03 Jun - close price
- Market Cap 10,622,017,000 USD
- Current Price $ 77.95
- High / Low $ 79.00 / 77.41
- Stock P/E 18.28
- Book Value 34.88
- EPS 4.28
- Next Earning Report 2026-08-06
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA 0.08 %
- ROE 0.13 %
- 52 Week High 101.40
- 52 Week Low 51.79
About
Globus Medical, Inc., a medical device company, develops and markets healthcare solutions for patients with musculoskeletal disorders. The company is headquartered in Audubon, Pennsylvania.
Analyst Target Price
$110.00
Quarterly Earnings
| Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-05-07 | 2026-02-24 | 2025-11-06 | 2025-08-07 | 2025-05-08 | 2025-02-20 | 2024-11-05 | 2024-08-06 | 2024-05-07 | 2024-02-20 | 2023-11-07 | 2023-08-03 |
| Reported EPS | 1.12 | 1.28 | 1.18 | 0.86 | 0.68 | 0.84 | 0.83 | 0.75 | 0.72 | 0.6 | 0.57 | 0.63 |
| Estimated EPS | 0.92 | 1.1536 | 0.78 | 0.75 | 0.75 | 0.7486 | 0.65 | 0.68 | 0.57 | 0.61 | 0.57 | 0.59 |
| Surprise | 0.2 | 0.1264 | 0.4 | 0.11 | -0.07 | 0.0914 | 0.18 | 0.07 | 0.15 | -0.01 | 0 | 0.04 |
| Surprise Percentage | 21.7391% | 10.957% | 51.2821% | 14.6667% | -9.3333% | 12.2095% | 27.6923% | 10.2941% | 26.3158% | -1.6393% | 0% | 6.7797% |
Next Quarterly Earnings
| Jun 2026 | |
|---|---|
| Reported Date | 2026-08-06 |
| Fiscal Date Ending | 2026-06-30 |
| Estimated EPS | 1.1 |
| Currency | USD |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: GMED
2026-06-01 01:09:51
This article provides the number of shareholders for Globus Medical Inc Class A (BX:GMED). It focuses specifically on the company's financials, offering data related to the "Period Value Change" and "Change %" for shareholders. The information is sourced from financial data providers like ICE Data Services and FactSet.
2026-05-24 10:10:25
Globus Medical (GMED) saw a 7.4% increase after reporting a strong Q1, exceeding earnings and revenue expectations, expanding adjusted EBITDA margins, and raising full-year non-GAAP EPS guidance. The company's performance is attributed to the integration of NuVasive and Nevro, alongside the broad implementation of generative AI across its operations to drive efficiency and growth. This technology and M&A driven strategy has initiated a re-evaluation of its investment narrative and risk profile.
2026-05-23 20:39:08
Globus Medical (GMED) has experienced recent share price volatility, with a 10.7% gain in the past week but a 10.7% drop over the last month. Despite these fluctuations, the stock has shown strong long-term performance and is currently assessed as undervalued by Simply Wall St's valuation models. Both a Discounted Cash Flow (DCF) analysis and a Price-to-Earnings (P/E) ratio comparison suggest significant undervaluation compared to its intrinsic value and industry peers.
2026-05-18 07:39:19
Globus Medical (GMED) reported strong Q1 2026 sales and net income, reaffirming its full-year 2026 revenue guidance of US$3.18–3.22 billion. The company also reiterated its strategy for capital allocation, focusing on R&D, manufacturing, share repurchases, and selective M&A to support long-term profitable growth. This disciplined approach to capital allocation, coupled with solid guidance, influences the investment narrative despite potential risks from extended sales cycles in robotics and integration challenges.
2026-05-17 06:38:58
Globus Medical (GMED) shares have dropped significantly despite solid quarterly results, including higher sales and earnings, and reaffirmed full-year revenue guidance. The company is currently considered 31.3% undervalued at $76.64 against a narrative fair value of $111.50, driven by expectations of growing global demand for spine and orthopedic solutions. However, potential risks include prolonged sales cycles for robotics and integration issues from recent acquisitions.
2026-05-13 12:14:00
This article from Stock Traders Daily discusses the technical signals for Globus Medical Inc. Class A (NASDAQ: GMED), noting weak near and mid-term sentiment despite a positive long-term outlook. It outlines three AI-generated trading strategies—Position, Momentum Breakout, and Risk Hedging—along with multi-timeframe signal analysis indicating support and resistance levels. The report emphasizes the use of AI models for optimizing position sizing and minimizing drawdown risk.
